DUBLIN, IRELAND--(Marketwired - November 19, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it will be presenting at the following conferences the first week in December:
27th Annual Piper Jaffray Healthcare Conference
- Presentation Date: December 1, 2015
- Presentation Time: 2 p.m. EST
- Location: New York
Bank of America Merrill Lynch 2015 Leveraged Finance Conference
- Presentation Date: December 3, 2015
- Presentation Time: 10:50 a.m. EST
- Location: Boca Raton
The presentations will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizon-pharma.com. A replay of each webcast will be available following the events.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon Pharma’s global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
Investors:
John Thomas
Executive Vice President, Corporate Strategy and Investor Relations
investor-relations@horizonpharma.com
Tina Ventura
Vice President, Investor Relations
investor-relations@horizonpharma.com
Media:
Geoff Curtis
Group Vice President, Corporate Communications
GCurtis@horizonpharma.com
